---
figid: PMC6207163__fig-2
figlink: /pmc/articles/PMC6207163/figure/f2/
number: <b>FIG. 2.</b>
caption: EGFR signaling pathways. Activation of EGFR by ligand binding leads to a
  myriad of downstream signaling pathways (e.g., PI3K/Akt pathway, Ras/Raf/MEK/ERK
  pathway, JAK/STAT pathway, and NF-κB pathway) that ultimately drive tumor cell growth,
  angiogenesis, invasion, etc. Note that PI3K is required for membrane recruitment
  of Rac, a NOX subunit, and the subsequent ROS production. EGFR-targeted monoclonal
  antibodies block ligand binding to the extracellular domain of EGFR. EGFR-targeted
  TKIs inhibit the catalytic domain of EGFR. Mechanisms for resistance to EGFR-targeted
  therapies include EGFR oxidation/mutation with increased/constitutive activity,
  activation of redundant kinase signaling pathways (e.g., c-MET and HER2), and EGFR-independent
  activation of downstream pathways (e.g., PI3K/Akt). Bold borders indicate redox-regulated
  proteins. Akt, protein kinase B; c-MET, tyrosine-protein kinase Met; EGF, epidermal
  growth factor; ERK, extracellular signal-regulated kinase; Grb2, growth factor receptor-bound
  protein 2; HER2, human epidermal growth factor receptor 2; IKK, IκB kinase; JAK,
  Janus kinase; MEK, mitogen-activated protein kinase kinase; mTOR, mechanistic target
  of rapamycin; NADPH, nicotinamide adenine dinucleotide phosphate; NF-κB, nuclear
  factor kappa-light-chain-enhancer of activated B cells; NOX, NADPH oxidase; PI3K,
  phosphatidylinositide 3-kinase; PRX, peroxiredoxin; PTEN, phosphatase and tensin
  homologue; Rac, Ras-related C3 botulinum toxin substrate; SHP2, tyrosine-protein
  phosphatase nonreceptor type 11; STAT, signal transducer and activator of transcription
  factor; TKI, tyrosine kinase inhibitor. To see this illustration in color, the reader
  is referred to the web version of this article at www.liebertpub.com/ars
pmcid: PMC6207163
papertitle: Modulators of Redox Metabolism in Head and Neck Cancer.
reftext: Xiaofei Chen, et al. Antioxid Redox Signal. 2018 Dec 1;29(16):1660-1690.
pmc_ranked_result_index: '64393'
pathway_score: 0.9510721
filename: fig-2.jpg
figtitle: Modulators of Redox Metabolism in Head and Neck Cancer
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6207163__fig-2.html
  '@type': Dataset
  description: EGFR signaling pathways. Activation of EGFR by ligand binding leads
    to a myriad of downstream signaling pathways (e.g., PI3K/Akt pathway, Ras/Raf/MEK/ERK
    pathway, JAK/STAT pathway, and NF-κB pathway) that ultimately drive tumor cell
    growth, angiogenesis, invasion, etc. Note that PI3K is required for membrane recruitment
    of Rac, a NOX subunit, and the subsequent ROS production. EGFR-targeted monoclonal
    antibodies block ligand binding to the extracellular domain of EGFR. EGFR-targeted
    TKIs inhibit the catalytic domain of EGFR. Mechanisms for resistance to EGFR-targeted
    therapies include EGFR oxidation/mutation with increased/constitutive activity,
    activation of redundant kinase signaling pathways (e.g., c-MET and HER2), and
    EGFR-independent activation of downstream pathways (e.g., PI3K/Akt). Bold borders
    indicate redox-regulated proteins. Akt, protein kinase B; c-MET, tyrosine-protein
    kinase Met; EGF, epidermal growth factor; ERK, extracellular signal-regulated
    kinase; Grb2, growth factor receptor-bound protein 2; HER2, human epidermal growth
    factor receptor 2; IKK, IκB kinase; JAK, Janus kinase; MEK, mitogen-activated
    protein kinase kinase; mTOR, mechanistic target of rapamycin; NADPH, nicotinamide
    adenine dinucleotide phosphate; NF-κB, nuclear factor kappa-light-chain-enhancer
    of activated B cells; NOX, NADPH oxidase; PI3K, phosphatidylinositide 3-kinase;
    PRX, peroxiredoxin; PTEN, phosphatase and tensin homologue; Rac, Ras-related C3
    botulinum toxin substrate; SHP2, tyrosine-protein phosphatase nonreceptor type
    11; STAT, signal transducer and activator of transcription factor; TKI, tyrosine
    kinase inhibitor. To see this illustration in color, the reader is referred to
    the web version of this article at www.liebertpub.com/ars
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - EGF
  - AKT3
  - RHOG
  - RAC2
  - RAC3
  - JAK1
  - JAK2
  - ARAF
  - JAK3
  - TYK2
  - MAP2K1
  - SRC
  - STAT3
  - CHUK
  - IKBKG
  - HRAS
  - EGFR
  - RAF1
  - BRAF
  - MAPK3
  - GRB2
  - MAPK1
  - NFKB1
  - KRAS
  - PTEN
  - IKBKB
  - MTOR
  - MAP2K2
  - PTPN11
  - RAC1
  - NRAS
  - Erlotinib
  - Afatinib
  - NADPH NADP
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals:
- word: Erlotinib
  source: MESH
  identifier: C400278
- word: Afatinib
  source: MESH
  identifier: C522924
- word: NADPH NADP
  source: MESH
  identifier: D009249
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
